Medicine

R. Coleman

2001.6.1CANCER TREATMENT REVIEWS

DOI: 10.1053/ctrv.2000.0210

tlooto Summary

Ongoing research is aimed at trying to define the optimum route, dose, schedule and type of bisphosphonate in metastatic bone disease and in the prevention and treatment of osteoporosis in cancer patients.

Abstract

Abstract is not available.

Citation format

COLEMAN, R. Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. CANCER TREATMENT REVIEWS, 2001, 27 3: 165–76.